Cohort profile: Copenhagen Hospital Biobank - Cardiovascular Disease Cohort (CHB-CVDC): Construction of a large-scale genetic cohort to facilitate a better understanding of heart diseases

Purpose The aim of Copenhagen Hospital Biobank-Cardiovascular Disease Cohort (CHB-CVDC) is to establish a cohort that can accelerate our understanding of CVD initiation and progression by jointly studying genetics, diagnoses, treatments and risk factors.Participants The CHB-CVDC is a large genomic c...

Full description

Saved in:
Bibliographic Details
Main Authors: Christian Torp-Pedersen, Lars Køber, Karina Banasik, Christian Erikstrup, David Westergaard, Mette Nyegaard, Erik Sørensen, Søren Brunak, Henrik Ullum, Kari Stefansson, Henning Bundgaard, Unnur Thorsteinsdottir, Ruth Frikke-Schmidt, Hreinn Stefánsson, Sisse R Ostrowski, Ina H Laursen, Amalie D Haue, Oscar Petersen, Peter C Holm, Hilma Holm, Lise W Thørner, Margit A H Larsen, Michael Schwinn, Arnaldur Gylfason, Florian Zink, G Bragi Walters, Asmundur Oddsson, Guðmar Þorleifsson, Gisli Másson, Daniel Gudbjartsson, Ole B Pedersen
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/12/e049709.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850169795135143936
author Christian Torp-Pedersen
Lars Køber
Karina Banasik
Christian Erikstrup
David Westergaard
Mette Nyegaard
Erik Sørensen
Søren Brunak
Henrik Ullum
Kari Stefansson
Henning Bundgaard
Unnur Thorsteinsdottir
Ruth Frikke-Schmidt
Hreinn Stefánsson
Sisse R Ostrowski
Ina H Laursen
Amalie D Haue
Oscar Petersen
Peter C Holm
Hilma Holm
Lise W Thørner
Margit A H Larsen
Michael Schwinn
Arnaldur Gylfason
Florian Zink
G Bragi Walters
Asmundur Oddsson
Guðmar Þorleifsson
Gisli Másson
Daniel Gudbjartsson
Ole B Pedersen
author_facet Christian Torp-Pedersen
Lars Køber
Karina Banasik
Christian Erikstrup
David Westergaard
Mette Nyegaard
Erik Sørensen
Søren Brunak
Henrik Ullum
Kari Stefansson
Henning Bundgaard
Unnur Thorsteinsdottir
Ruth Frikke-Schmidt
Hreinn Stefánsson
Sisse R Ostrowski
Ina H Laursen
Amalie D Haue
Oscar Petersen
Peter C Holm
Hilma Holm
Lise W Thørner
Margit A H Larsen
Michael Schwinn
Arnaldur Gylfason
Florian Zink
G Bragi Walters
Asmundur Oddsson
Guðmar Þorleifsson
Gisli Másson
Daniel Gudbjartsson
Ole B Pedersen
author_sort Christian Torp-Pedersen
collection DOAJ
description Purpose The aim of Copenhagen Hospital Biobank-Cardiovascular Disease Cohort (CHB-CVDC) is to establish a cohort that can accelerate our understanding of CVD initiation and progression by jointly studying genetics, diagnoses, treatments and risk factors.Participants The CHB-CVDC is a large genomic cohort of patients with CVD. CHB-CVDC currently includes 96 308 patients. The cohort is part of CHB initiated in 2009 in the Capital Region of Denmark. CHB is continuously growing with ~40 000 samples/year. Patients in CHB were included in CHB-CVDC if they were above 18 years of age and assigned at least one cardiovascular diagnosis. Additionally, up-to 110 000 blood donors can be analysed jointly with CHB-CVDC. Linkage with the Danish National Health Registries, Electronic Patient Records, and Clinical Quality Databases allow up-to 41 years of medical history. All individuals are genotyped using the Infinium Global Screening Array from Illumina and imputed using a reference panel consisting of whole-genome sequence data from 8429 Danes along with 7146 samples from North-Western Europe. Currently, 39 539 of the patients are deceased.Findings to date Here, we demonstrate the utility of the cohort by showing concordant effects between known variants and selected CVDs, that is, >93% concordance for coronary artery disease, atrial fibrillation, heart failure and cholesterol measurements and 85% concordance for hypertension. Furthermore, we evaluated multiple study designs and the validity of using Danish blood donors as part of CHB-CVDC. Lastly, CHB-CVDC has already made major contributions to studies of sick sinus syndrome and the role of phytosterols in development of atherosclerosis.Future plans In addition to genetics, electronic patient records, national socioeconomic and health registries extensively characterise each patient in CHB-CVDC and provides a promising framework for improved understanding of risk and protective variants. We aim to include other measurable biomarkers for example, proteins in CHB-CVDC making it a platform for multiomics cardiovascular studies.
format Article
id doaj-art-a34d0f1752f84b5fada1b74199daa31c
institution OA Journals
issn 2044-6055
language English
publishDate 2021-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-a34d0f1752f84b5fada1b74199daa31c2025-08-20T02:20:38ZengBMJ Publishing GroupBMJ Open2044-60552021-12-01111210.1136/bmjopen-2021-049709Cohort profile: Copenhagen Hospital Biobank - Cardiovascular Disease Cohort (CHB-CVDC): Construction of a large-scale genetic cohort to facilitate a better understanding of heart diseasesChristian Torp-Pedersen0Lars Køber1Karina Banasik2Christian Erikstrup3David Westergaard4Mette Nyegaard5Erik Sørensen6Søren Brunak7Henrik Ullum8Kari Stefansson9Henning Bundgaard10Unnur Thorsteinsdottir11Ruth Frikke-Schmidt12Hreinn Stefánsson13Sisse R Ostrowski14Ina H Laursen15Amalie D Haue16Oscar Petersen17Peter C Holm18Hilma Holm19Lise W Thørner20Margit A H Larsen21Michael Schwinn22Arnaldur Gylfason23Florian Zink24G Bragi Walters25Asmundur Oddsson26Guðmar Þorleifsson27Gisli Másson28Daniel Gudbjartsson29Ole B Pedersen30Cardiology, North Zealand Hospital, Hilleroed, DenmarkDepartment of Cardiology, Rigshospitalet, Copenhagen, DenmarkNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DenmarkDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, DenmarkNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DenmarkHealth Science and Technology, Aalborg Universitet, Gistrup, DenmarkDepartment of Clinical Immunology, Section 2034, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark3 Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark13 Statens Serum Institut, Copenhagen, Denmark2 deCODE genetics/Amgen, Reykjavik, IcelandDepartment of Cardiology, Rigshospitalet, Copenhagen, DenmarkdeCODE genetics, Reykjavik, IcelandDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkdeCODE genetics, Reykjavik, IcelandDepartment of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, DenmarkDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DenmarkDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DenmarkdeCODE genetics, Reykjavik, IcelandDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkDepartment of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, DenmarkdeCODE genetics, Reykjavik, IcelanddeCODE genetics, Reykjavik, IcelanddeCODE genetics, Reykjavik, IcelanddeCODE genetics, Reykjavik, IcelanddeCODE genetics, Reykjavik, IcelanddeCODE genetics, Reykjavik, IcelanddeCODE genetics, Reykjavik, IcelandDepartment of Clinical Immunology, Zealand University Hospital Køge, Køge, DenmarkPurpose The aim of Copenhagen Hospital Biobank-Cardiovascular Disease Cohort (CHB-CVDC) is to establish a cohort that can accelerate our understanding of CVD initiation and progression by jointly studying genetics, diagnoses, treatments and risk factors.Participants The CHB-CVDC is a large genomic cohort of patients with CVD. CHB-CVDC currently includes 96 308 patients. The cohort is part of CHB initiated in 2009 in the Capital Region of Denmark. CHB is continuously growing with ~40 000 samples/year. Patients in CHB were included in CHB-CVDC if they were above 18 years of age and assigned at least one cardiovascular diagnosis. Additionally, up-to 110 000 blood donors can be analysed jointly with CHB-CVDC. Linkage with the Danish National Health Registries, Electronic Patient Records, and Clinical Quality Databases allow up-to 41 years of medical history. All individuals are genotyped using the Infinium Global Screening Array from Illumina and imputed using a reference panel consisting of whole-genome sequence data from 8429 Danes along with 7146 samples from North-Western Europe. Currently, 39 539 of the patients are deceased.Findings to date Here, we demonstrate the utility of the cohort by showing concordant effects between known variants and selected CVDs, that is, >93% concordance for coronary artery disease, atrial fibrillation, heart failure and cholesterol measurements and 85% concordance for hypertension. Furthermore, we evaluated multiple study designs and the validity of using Danish blood donors as part of CHB-CVDC. Lastly, CHB-CVDC has already made major contributions to studies of sick sinus syndrome and the role of phytosterols in development of atherosclerosis.Future plans In addition to genetics, electronic patient records, national socioeconomic and health registries extensively characterise each patient in CHB-CVDC and provides a promising framework for improved understanding of risk and protective variants. We aim to include other measurable biomarkers for example, proteins in CHB-CVDC making it a platform for multiomics cardiovascular studies.https://bmjopen.bmj.com/content/11/12/e049709.full
spellingShingle Christian Torp-Pedersen
Lars Køber
Karina Banasik
Christian Erikstrup
David Westergaard
Mette Nyegaard
Erik Sørensen
Søren Brunak
Henrik Ullum
Kari Stefansson
Henning Bundgaard
Unnur Thorsteinsdottir
Ruth Frikke-Schmidt
Hreinn Stefánsson
Sisse R Ostrowski
Ina H Laursen
Amalie D Haue
Oscar Petersen
Peter C Holm
Hilma Holm
Lise W Thørner
Margit A H Larsen
Michael Schwinn
Arnaldur Gylfason
Florian Zink
G Bragi Walters
Asmundur Oddsson
Guðmar Þorleifsson
Gisli Másson
Daniel Gudbjartsson
Ole B Pedersen
Cohort profile: Copenhagen Hospital Biobank - Cardiovascular Disease Cohort (CHB-CVDC): Construction of a large-scale genetic cohort to facilitate a better understanding of heart diseases
BMJ Open
title Cohort profile: Copenhagen Hospital Biobank - Cardiovascular Disease Cohort (CHB-CVDC): Construction of a large-scale genetic cohort to facilitate a better understanding of heart diseases
title_full Cohort profile: Copenhagen Hospital Biobank - Cardiovascular Disease Cohort (CHB-CVDC): Construction of a large-scale genetic cohort to facilitate a better understanding of heart diseases
title_fullStr Cohort profile: Copenhagen Hospital Biobank - Cardiovascular Disease Cohort (CHB-CVDC): Construction of a large-scale genetic cohort to facilitate a better understanding of heart diseases
title_full_unstemmed Cohort profile: Copenhagen Hospital Biobank - Cardiovascular Disease Cohort (CHB-CVDC): Construction of a large-scale genetic cohort to facilitate a better understanding of heart diseases
title_short Cohort profile: Copenhagen Hospital Biobank - Cardiovascular Disease Cohort (CHB-CVDC): Construction of a large-scale genetic cohort to facilitate a better understanding of heart diseases
title_sort cohort profile copenhagen hospital biobank cardiovascular disease cohort chb cvdc construction of a large scale genetic cohort to facilitate a better understanding of heart diseases
url https://bmjopen.bmj.com/content/11/12/e049709.full
work_keys_str_mv AT christiantorppedersen cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT larskøber cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT karinabanasik cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT christianerikstrup cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT davidwestergaard cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT mettenyegaard cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT eriksørensen cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT sørenbrunak cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT henrikullum cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT karistefansson cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT henningbundgaard cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT unnurthorsteinsdottir cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT ruthfrikkeschmidt cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT hreinnstefansson cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT sisserostrowski cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT inahlaursen cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT amaliedhaue cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT oscarpetersen cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT petercholm cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT hilmaholm cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT lisewthørner cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT margitahlarsen cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT michaelschwinn cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT arnaldurgylfason cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT florianzink cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT gbragiwalters cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT asmunduroddsson cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT guðmarþorleifsson cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT gislimasson cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT danielgudbjartsson cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases
AT olebpedersen cohortprofilecopenhagenhospitalbiobankcardiovasculardiseasecohortchbcvdcconstructionofalargescalegeneticcohorttofacilitateabetterunderstandingofheartdiseases